Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Polomar Health ServicesPMHS Return-on-Tangible-Asset is -22.05% as of Mar. 2026. The stock has 4 warning signs investors should review. Among 680 Healthcare Providers & Services companies, Polomar Health Services ranks worse than 99.56% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Polomar Health Services's annualizedNet Income for the quarter that ended in Mar. 2026 was $-0.10 Mil. Polomar Health Services's average total tangible assets for the quarter that ended in Mar. 2026 was $0.45 Mil. Therefore, Polomar Health Services's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was -22.05%.
The historical rank and industry rank for Polomar Health Services's Return-on-Tangible-Asset or its related term are showing as below:
PMHS'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -3525.86 Med: -340 Max: -64.71
Current: -3002.92
During the past 7 years, Polomar Health Services's highest Return-on-Tangible-Asset was -64.71%. The lowest was -3525.86%. And the median was -340.00%.
PMHS's Return-on-Tangible-Asset is ranked worse than 99.56% of 680
companies
in the Healthcare Providers & Services industry
Industry Median: 2.505
vs PMHS: -3002.92
Polomar Health Services (OTCPK:PMHS) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Polomar Health Services Return-on-Tangible-Asset Related Terms
Polomar Health Services Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Polomar Health Services's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Polomar Health Services Return-on-Tangible-Asset Chart
PMHS vs DHTI, RDGT, BLMH: Return-on-Tangible-Asset Comparison
For the Pharmaceutical Retailers subindustry, Polomar Health Services's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Polomar Health Services Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Polomar Health Services's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Polomar Health Services's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of -22.05% mean?
Polomar Health Services (PMHS) has a Return-on-Tangible-Asset of -22.05% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Polomar Health Services and its competitors. According to the industry distribution chart, Polomar Health Services ranks #677 out of 680 companies in the Healthcare Providers & Services industry, placing it in the top 99.6%.
Is Polomar Health Services' Return-on-Tangible-Asset too high?
Polomar Health Services' current Return-on-Tangible-Asset is -22.05%. Based on the distribution chart, Polomar Health Services ranks #677 out of 680 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Polomar Health Services' Return-on-Tangible-Asset compare to DHTI and RDGT?
According to the Healthcare Providers & Services industry distribution chart, Polomar Health Services ranks #677 out of 680 companies for Return-on-Tangible-Asset. This places Polomar Health Services in the lower half of its industry. The industry median Return-on-Tangible-Asset is 2.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.51, based on 680 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Polomar Health Services and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Polomar Health Services's current Return-on-Tangible-Asset is -22.05%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polomar Health Services stock overvalued right now?
Based on GuruFocus' analysis, Polomar Health Services (PMHS) is currently considered Possible Value Trap. The stock's GF Value™ is $12.51, compared to a current price of $0.08 — trading 99.4% below its estimated fair value. The current Return-on-Tangible-Asset is -22.05%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Polomar Health Services (PMHS), the current Return-on-Tangible-Asset is -22.05% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Polomar Health Services Inc is a U.S.-based healthcare company specializing in retail compounding pharmacy services and prescription fulfillment for telehealth platforms. It is also licensed as a Special Sterile Compounding Pharmacy, permit #PH35277, which authorizes the licensed entity to dispense injectable and other sterile compounds (eye drops, infused therapeutics) upon receipt of a valid prescription. The firm is presently licensed and authorized to fulfill and deliver compounded prescribed medications in 28 states.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PMHS has been successfully added to your 
